Skip to main content
. 2021 Mar 22;19:38. doi: 10.1186/s12969-021-00510-8

Table 4.

Concurrent medication: Children received disease-modifying antirheumatic drugs (DMARDs), [methotrexate (MTX), cyclosporine A (CSA), azathioprine (AZA)], biologicals [etanercept (ETA), tocilizumab (TCZ), adalimumab (ADA), rituximab (RTX)], nonsteroidal anti-inflammatory drugs (NSAIDs), and corticosteroids (CO).

graphic file with name 12969_2021_510_Tab4_HTML.jpg